Second Line Treatment of Gastric Cancer
1 clinical trials · Condition
◉ Watch Second Line Treatment of Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer (NCT05669807) | Zhejiang Cancer Hospital | 2022-12-01 |
Track Second Line Treatment of Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.